Overview Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex Status: Completed Trial end date: 2008-01-28 Target enrollment: Participant gender: Summary Study aimed to evaluate the efficacy and tolerance of Lazolex®, an emollient gel, to treat mucocutaneous lesions caused by herpes simplex virus. Phase: Phase 2 Details Lead Sponsor: Iveriapharma LLC